AAA
RETA

Affinity Asset Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Affinity Asset Advisors’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-29,105
Closed -$2.97M – 87
2023
Q2 		$2.97M Buy
+29,105
New +$2.97M 1.04% 27